Large gap with delayed quotes
Analysis date: 10.10.2025
Global Evaluation
Positive
Positive
The stock is classified in the positive zone since 26.09.2025.
Interest
Very strong
Very strong
Four stars since 26.09.2025.
Earnings Rev Trend
Positive
Positive
Compared to seven weeks ago, the analysts have raised their earnings per share estimates. This positive trend began 26.09.2025 at a price of 58.40.
Evaluation
Undervalued
Undervalued
Based on its growth potential and our own criteria, we believe the share price is currently moderately undervalued.
MT Tech Trend
Positive
Positive
The dividend-adjusted forty day technical trend is positive since 02.05.2025.
4wk Rel Perf
8.64%
8.64%
The four-week dividend-adjusted overperformance versus STOXX600 is 8.64%.
Sensibility
Low
Low
The stock has been on the low-sensitivity level since 14.01.2025.
Bear Market Factor
Low
Low
On average, the stock has a tendency to minimize the drops in the index by 0.04%.
Bad News Factor
Low
Low
When the stock's pressure is specific, the market sanction on average is 2.45%.
Mkt Cap in $bn
156.54
156.54
With a market capitalization >$8bn, PROSUS is considered a large-cap stock.
G/PE Ratio
1.28
1.28
A ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) higher than 0.9 indicates that the stock's price presents a discount to growth of
LT P/E
12.90
12.90
The estimated PE is for the year 2028.
LT Growth
16.23%
16.23%
The annualized growth estimate is for the current year to 2028.
Avg. Nb analysts
11
11
Over the last seven weeks, an average of 11 analysts provided earnings per share estimates.
Dividend Yield
0.31%
0.31%
The twelve month estimated dividend yield represents 3.99% of earnings forecasts.
Beta
144
144
For 1% of index variation, the stock varies on average by 1.44%.
Correlation
0.66
0.66
65.52% of stock movements are explained by index variations.
Value at Risk
7.11
7.11
The value at risk is estimated at EUR 7.11. The risk is therefore 12.00%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
03.12.2019
03.12.2019